.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Buspirone hydrochloride - Generic Drug Details

« Back to Dashboard
Buspirone hydrochloride is the generic ingredient in two branded drugs marketed by Oxford Pharms, Mylan, Sandoz, Egis, Apotex, Teva, Strides Arcolab Ltd, Bristol Myers Squibb, Dr Reddys Labs Ltd, Impax Labs Inc, Accord Hlthcare, Nesher Pharms, Heritage Pharma, Ivax Sub Teva Pharms, Orion Corp Orion, and Zydus Pharms Usa Inc, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for buspirone hydrochloride. Forty-seven suppliers are listed for this compound.

Summary for Generic Name: buspirone hydrochloride

Tradenames:2
Patents:0
Applicants:16
NDAs:20
Drug Master File Entries: see list18
Suppliers / Packaging: see list47
Therapeutic Class:Anxiolytics
Formulation / Manufacturing:see details
Drug Prices:see low prices
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oxford Pharms
BUSPIRONE HYDROCHLORIDE
buspirone hydrochloride
TABLET;ORAL075388-002May 9, 2002DISCNNo► subscribe► subscribe
Orion Corp Orion
BUSPIRONE HYDROCHLORIDE
buspirone hydrochloride
TABLET;ORAL202087-003Dec 16, 2015RXNo► subscribe► subscribe
Heritage Pharma
BUSPIRONE HYDROCHLORIDE
buspirone hydrochloride
TABLET;ORAL204582-002Sep 18, 2015RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: buspirone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb
BUSPAR
buspirone hydrochloride
TABLET;ORAL018731-004Apr 22, 19964,258,027► subscribe
Bristol Myers Squibb
BUSPAR
buspirone hydrochloride
TABLET;ORAL018731-001Sep 29, 19865,015,646*PED► subscribe
Bristol Myers Squibb
BUSPAR
buspirone hydrochloride
CAPSULE;ORAL021190-001Dec 20, 20005,015,646*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc